ARCHIVES

FDA Approves Imaging Agent For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

New Carfilzomib Combination Produces Near Remissions

June 29, 2012

No difference between digital or film mammograms, study finds.

September 23, 2005

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013

FDA Seeks Consumers For Advisory Committees.

November 23, 2001

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003